GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Panacos Pharmaceuticals Inc (GREY:PANC) » Definitions » Short-Term Debt & Capital Lease Obligation

Panacos Pharmaceuticals (Panacos Pharmaceuticals) Short-Term Debt & Capital Lease Obligation : $7.05 Mil (As of Sep. 2008)


View and export this data going back to 1998. Start your Free Trial

What is Panacos Pharmaceuticals Short-Term Debt & Capital Lease Obligation?

Short-Term Debt & Capital Lease Obligation is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt. Panacos Pharmaceuticals's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2008 was $7.05 Mil.

Long-Term Debt & Capital Lease Obligation is the debt and capital lease obligation due more than 12 months in the future. Panacos Pharmaceuticals's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2008 was $11.15 Mil.


Panacos Pharmaceuticals Short-Term Debt & Capital Lease Obligation Historical Data

The historical data trend for Panacos Pharmaceuticals's Short-Term Debt & Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Panacos Pharmaceuticals Short-Term Debt & Capital Lease Obligation Chart

Panacos Pharmaceuticals Annual Data
Trend Dec98 Dec99 Dec00 Dec01 Dec02 Dec03 Dec04 Dec05 Dec06 Dec07
Short-Term Debt & Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.13 0.21 0.36 2.78

Panacos Pharmaceuticals Quarterly Data
Dec03 Mar04 Jun04 Sep04 Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08
Short-Term Debt & Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 2.78 4.53 6.34 7.05

Panacos Pharmaceuticals Short-Term Debt & Capital Lease Obligation Calculation

This is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt.

In the notes to balance sheet in annual (10-K) or quarterly (10-Q) reports, companies usually break down the details of the debt, their due dates, the interest rates etc.


Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term


Panacos Pharmaceuticals Short-Term Debt & Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Panacos Pharmaceuticals's Short-Term Debt & Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


Panacos Pharmaceuticals (Panacos Pharmaceuticals) Business Description

Industry
Traded in Other Exchanges
N/A
Address
134 Coolidge Avenue, Watertown, MA, USA, 02472
Panacos Pharmaceuticals Inc is a biotechnology company that seeks to develop next generation anti-infective products through the discovery and development of small-molecule oral drugs designed to treat HIV and other human viral diseases.

Panacos Pharmaceuticals (Panacos Pharmaceuticals) Headlines

No Headlines